Mankind Pharma Limited
MANKIND
株式のランク
#2064
Mankind Pharma Limited specializes in the development, manufacturing, and... Mankind Pharma Limited specializes in the development, manufacturing, and marketing of a broad range of pharmaceutical medications and consumer health goods. Operating predominantly in India, the company also caters to international markets. Its pharmaceutical division focuses on both acute and chronic therapeutic areas, encompassing a wide spectrum of medical conditions such as infectious diseases, cardiovascular ailments, gastrointestinal disorders, diabetes, dermatology, pain management, neuro/CNS issues, nutritional support (vitamins/minerals), and respiratory problems. Complementing its pharmaceutical portfolio, the consumer healthcare segment offers diverse products, including condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. Key brands under its umbrella include Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar. Furthermore, the company's business activities are diversified, extending to the trading and export of pharmaceutical and healthcare products, as well as the manufacturing of various goods such as packaging materials, ayurvedic products, bulk drugs, and general consumer items. Mankind Pharma also holds interests in real estate, leasing, hospitality, and IT services. Established in 1986, Mankind Pharma Limited maintains its headquarters in New Delhi, India.
株価
$24.08
時価総額
$9.95B
変化（1日）
-4.09%
変化（1年）
-13.33%
国
IN
取引 Mankind Pharma Limited (MANKIND)
カテゴリー
Healthcare
Mankind Pharma Limited（MANKIND）の収益
Oct 2026 時点の収益 TTM: 0
Mankind Pharma Limited の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Mankind Pharma Limited の収益履歴（2019 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2025 | $1.43B | 16.01% |
| 2024 | $1.23B | 15.57% |
| 2023 | $1.06B | 3.86% |
| 2022 | $1.03B | 20.75% |
| 2021 | $848.92M | 9.04% |
| 2020 | $778.55M | 8.56% |
| 2019 | $717.16M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | - |
IN
|
